Improving diabetes competencies in dietitians: Evaluation of a training programme by Hargreaves, A, Dyson, P

Analyses of GC evolution in gerbil genomes by Hargreaves, A, Pracana, R

Other Authors: “…Hargreaves, A…”

Effects on ventricular arrhythmias of oral captopril and of oral mononitrate started early in acute myocardial infarction: results of a randomised placebo controlled trial. by Pipilis, A, Flather, M, Collins, R, Hargreaves, A, Kolettis, T, Boon, N, Foster, C, Appleby, P, Sleight, P

Evaluation of a structured education session for women with gestational diabetes by Dyson, P, Hargreaves, A, Roberts, S, Bradbury, L, Ions, A, Job, N, Hirst, J, Kenworthy, Y, Jebb, S, Mackillop, L

GDm-Health Plus: Development of a remote behavioural lifestyle management system for women with gestational diabetes by Dyson, P, Hirst, J, Bartlett, C, Kenworthy, Y, Hargreaves, A, Roberts, S, Velardo, C, Jebb, S, Tarassenko, L, Mackillop, L

Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemody... by Flather, M, Pipilis, A, Collins, R, Budaj, A, Hargreaves, A, Kolettis, T, Jacob, A, Millane, T, Fitzgerald, L, Cedro, K

Genome sequence of a diabetes-prone rodent reveals a mutation hotspot around the ParaHox gene cluster by Hargreaves, A, Zhou, L, Christensen, J, Marletaz, F, Liu, S, Li, F, Jansen, P, Spiga, E, Hansen, M, Pedersen, S, Biswas, S, Serikawa, K, Fox, B, Taylor, W, Mulley, J, Zhang, G, Heller, R, Holland, P

RANDOMIZED CONTROLLED TRIAL OF ORAL CAPTOPRIL, OF ORAL ISOSORBIDE MONONITRATE AND OF INTRAVENOUS MAGNESIUM-SULFATE STARTED EARLY IN ACUTE MYOCARDIAL-INFARCTION - SAFETY AND HEMODYN... by Flather, M, Pipilis, A, Collins, R, Budaj, A, Hargreaves, A, Kolettis, T, Jacob, A, Millane, T, Fitzgerald, L, Cedro, K, Cybulski, J, Dancy, M, Appleby, P, Conway, M, Foster, C, Jackson, D, Lloyd, P, Parish, S, Peto, R, Boon, N, Bennett, D, Ceremuzynski, L, Sleight, P, Kurleto, J, Maciejewicz, J

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine by Payne, RP, Longet, S, Austin, JA, Skelly, DT, Dejnirattisai, W, Adele, S, Meardon, N, Faustini, S, Al-Taei, S, Moore, SC, Tipton, T, Hering, LM, Angyal, A, Brown, R, Nicols, AR, Gillson, N, Dobson, SL, Amini, A, Supasa, P, Cross, A, Bridges-Webb, A, Reyes, LS, Linder, A, Sandhar, G, Kilby, JA, Tyerman, JK, Altmann, T, Hornsby, H, Whitham, R, Phillips, E, Malone, T, Hargreaves, A, Shields, A, Saei, A, Foulkes, S, Stafford, L, Johnson, S, Wootton, DG, Conlon, CP, Jeffery, K, Matthews, PC, Frater, J, Deeks, AS, Pollard, AJ, Brown, A, Rowland-Jones, SL, Mongkolsapaya, J, Barnes, E, Hopkins, S, Hall, V, Dold, C, Duncan, CJA, Richter, A, Carroll, M, Screaton, G, de Silva, TI, Turtle, L, Klenerman, P, Dunachie, S